TNFSF10 and melanoma: The fact that the demise of cancer cells, such as melanoma cells, is delayed and less efficient compared to normal cells (62) also due to the deplyoment of counterattack strategies such as secretion of FasL+ and APO2L/TRAIL+ EVs (63), suggests a requirement for all three mechanisms for efficient killing.